The Department of Health and Human Services is offering a grant to develop Virtual Reality (VR) technologies for enhancing Substance Use Disorder (SUD) treatment, chronic pain management, and clinical research tools. This grant aims to validate and test the efficacy of VR platforms in supporting SUD treatment and comorbid mental illness disorders. Phase I focuses on feasibility and validation of the device, while Phase II evaluates efficacy in a larger sample. Successful projects will use data from VR studies for a FDA 510k submission to seek medical device clearance.
Opportunity ID: 311906
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-19-033 |
| Funding Opportunity Title: | Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R43/R44 – Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 11, 2019 |
| Last Updated Date: | Jan 11, 2019 |
| Original Closing Date for Applications: | Mar 20, 2019 |
| Current Closing Date for Applications: | Mar 20, 2019 |
| Archive Date: | Apr 25, 2019 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. See the funding announcements for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement is to develop and evaluate Virtual Reality (VR) enhanced technologies that will support SUD treatment and recovery, provide treatment alternatives for chronic pain, or serve as next generation Clinical Research Tools which leverage data from the VR experience and identify digital markers that model SUD and comorbid mental illness disorders. The objective of Phase I (R43) is to establish the feasibility and/or validation of the device, and Phase 2 is designed to test the efficacy of the VR platform in a larger sample. For VR digital therapeutics, data generated from these studies are to be used to support a 510k submission to seek clearance as an FDA medical device. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-033.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | FORMS-E | PKG00247484 | Feb 20, 2019 | Mar 20, 2019 | View |
Package 1
Mandatory forms
311906 RR_SF424_2_0-2.0.pdf
311906 PHS398_CoverPageSupplement_4_0-4.0.pdf
311906 RR_OtherProjectInfo_1_4-1.4.pdf
311906 PerformanceSite_2_0-2.0.pdf
311906 RR_KeyPersonExpanded_2_0-2.0.pdf
311906 RR_Budget_1_4-1.4.pdf
311906 PHS398_ResearchPlan_4_0-4.0.pdf
311906 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
311906 RR_SubawardBudget30_1_4-1.4.pdf
311906 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
